EP2529793A3 - Compositions pour la régulation ou la modulation de la détection de quorum dans des bactéries, procédés d'utilisation de ces composés et méthodes permettant de réguler ou moduler la détection de quorum dans des bactéries - Google Patents

Compositions pour la régulation ou la modulation de la détection de quorum dans des bactéries, procédés d'utilisation de ces composés et méthodes permettant de réguler ou moduler la détection de quorum dans des bactéries Download PDF

Info

Publication number: EP2529793A3
Authority: EP; European Patent Office
Prior art keywords: methods; bacteria; quorum sensing; regulating; present disclosure
Prior art date: 2007-06-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP20120178747

Other languages

German (de)

English (en)

Other versions

EP2529793B1 (fr

EP2529793A2 (fr

Inventor

Binghe Wang

Nantin Ni

Junfeng Wamg

Chung-Dar Lu

Han-Ting Chou

Minyong Li

Shilong Zheng

Yunfeg Cheng

Hanjing Peng

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Georgia State University Research Foundation Inc

Original Assignee

Georgia State University Research Foundation Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-08

Filing date

2008-06-06

Publication date

2013-03-20

2008-06-06 Application filed by Georgia State University Research Foundation Inc filed Critical Georgia State University Research Foundation Inc

2012-12-05 Publication of EP2529793A2 publication Critical patent/EP2529793A2/fr

2013-03-20 Publication of EP2529793A3 publication Critical patent/EP2529793A3/fr

2016-08-10 Application granted granted Critical

2016-08-10 Publication of EP2529793B1 publication Critical patent/EP2529793B1/fr

Status Not-in-force legal-status Critical Current

2028-06-06 Anticipated expiration legal-status Critical

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

EP12178747.7A 2007-06-08 2008-06-06 Compositions pour la régulation ou la modulation de la détection de quorum dans des bactéries, procédés d'utilisation de ces composés et méthodes permettant de réguler ou moduler la détection de quorum dans des bactéries Not-in-force EP2529793B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US93373507P	2007-06-08	2007-06-08
EP08828361A EP2155705A4 (fr)	2007-06-08	2008-06-06	Compositions permettant de réguler ou de moduler la détection du quorum dans une bactérie, procédés d'utilisation de ces composés et procédés de régulation et de modulation de la détection du quorum dans une bactérie

Related Parent Applications (2)

Application Number	Title	Priority Date	Filing Date
EP08828361.9 Division		2008-06-06
EP08828361A Division EP2155705A4 (fr)	2007-06-08	2008-06-06	Compositions permettant de réguler ou de moduler la détection du quorum dans une bactérie, procédés d'utilisation de ces composés et procédés de régulation et de modulation de la détection du quorum dans une bactérie

Publications (3)

Publication Number	Publication Date
EP2529793A2 EP2529793A2 (fr)	2012-12-05
EP2529793A3 true EP2529793A3 (fr)	2013-03-20
EP2529793B1 EP2529793B1 (fr)	2016-08-10

Family

ID=40388083

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EP12178747.7A Not-in-force EP2529793B1 (fr)	2007-06-08	2008-06-06	Compositions pour la régulation ou la modulation de la détection de quorum dans des bactéries, procédés d'utilisation de ces composés et méthodes permettant de réguler ou moduler la détection de quorum dans des bactéries
EP08828361A Withdrawn EP2155705A4 (fr)	2007-06-08	2008-06-06	Compositions permettant de réguler ou de moduler la détection du quorum dans une bactérie, procédés d'utilisation de ces composés et procédés de régulation et de modulation de la détection du quorum dans une bactérie

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
EP08828361A Withdrawn EP2155705A4 (fr)	2007-06-08	2008-06-06	Compositions permettant de réguler ou de moduler la détection du quorum dans une bactérie, procédés d'utilisation de ces composés et procédés de régulation et de modulation de la détection du quorum dans une bactérie

Country Status (3)

Country	Link
US (1)	US8653258B2 (fr)
EP (2)	EP2529793B1 (fr)
WO (1)	WO2009029317A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5612269B2 (ja) *	2009-04-24	2014-10-22	花王株式会社	歯周病マーカー
US8952192B2 (en)	2011-03-24	2015-02-10	University Of Maryland, College Park	Phosphorylated and branched dihydroxy-pentane-dione (DPD) analogs as quorum sensing inhibitors in bacteria
US10039777B2 (en)	2012-03-20	2018-08-07	Neuro-Lm Sas	Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
WO2014060581A1 (fr) *	2012-10-18	2014-04-24	Seprox Biotech, S.L.	Utilisation de l'hydroxytirosol et de ses dérivés comme désactivateurs de quorum
EP3151733B1 (fr) *	2014-06-06	2020-04-15	The Regents Of The University Of Michigan	Compositions et méthodes de caractérisation et de diagnostic d'une maladie parodontale
WO2016191816A1 (fr) *	2015-06-02	2016-12-08	The University Of Melbourne	Capsules d'acide phenylborate sensibles au glucose pour l'administration d'insuline
CN106074469B (zh) *	2015-06-19	2019-04-16	复旦大学附属华山医院	用于抗万古霉素耐药菌的药物组合物
CN111684019B (zh)	2018-02-13	2022-08-02	住友化学株式会社	组合物及成形体
US11638759B2 (en)	2019-08-13	2023-05-02	Darlene E. McCord	Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
WO2023076855A1 (fr)	2021-10-25	2023-05-04	Mccord Darlene E	Compositions d'argile médicinale enrobées, compositions pharmaceutiques et administration de sources de cations et leurs procédés d'utilisation

Citations (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2063870A (en) *	1979-07-05	1981-06-10	Bellon Labor Sa Roger	1-aryl-4-arylsulphonyl-1h-pyrazolol-3 compounds and processes for their preparation
US5308860A (en) *	1993-01-15	1994-05-03	Rohm And Haas Company	Cyanosulfonylethyltriazoles
WO1999010321A2 (fr) *	1997-08-29	1999-03-04	The Johns Hopkins University	Composes antimicrobiens
WO2002047681A1 (fr) *	2000-12-14	2002-06-20	Unisearch Limited	Regulation de la virulence de bacteries
WO2003018029A1 (fr) *	2001-08-24	2003-03-06	Quorex Pharmaceuticals, Inc.	Agents antibacteriens bases sur une liaison toxoanion
WO2003077844A2 (fr) *	2002-03-13	2003-09-25	Takara Bio, Inc.	Effet d'un traitement au 4,5-dihydroxy- 2-cyclopentene-1-one (dhcp) sur l'expression genique et la densite bacterienne (quorum sensing)
WO2004004712A1 (fr) *	2002-07-09	2004-01-15	Fasgen, Llc	Methodes de traitement d'infections microbiennes chez les humains et les animaux
US20040180829A1 (en) *	2000-05-10	2004-09-16	Bassler Bonnie L.	Compounds and methods for regulating bacterial growth and pathogenesis
WO2005005598A2 (fr) *	2003-04-11	2005-01-20	New York University	Prevention et traitement des infections provoquees par b.anthracis : b.anthracis mutante ne possedant pas l'activite luxs, et inhibition par des furanones de la croissance et du 'quorum sensing'' par le biais de ai-2, et production de toxines
WO2005021559A2 (fr) *	2003-09-02	2005-03-10	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Oxazaborolidines constituant des effecteurs bacteriens
WO2005100384A2 (fr) *	2004-04-12	2005-10-27	The Trustees Of Princeton University	Composes ai-2 et analogues bases sur la structure lsrb de salmonella typhimurium

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8506792D0 (en)	1985-03-15	1985-04-17	Janssen Pharmaceutica Nv	Derivatives of y-cyclodextrin
JPH01221375A (ja) *	1988-02-27	1989-09-04	Nippon Nohyaku Co Ltd	ジチオラン誘導体
AU3201095A (en) *	1994-07-27	1996-02-22	G.D. Searle & Co.	Substituted thiazoles for the treatment of inflammation
JP2002504122A (ja) *	1997-06-13	2002-02-05	ノースウエスタンユニバーシティー	ベータラクタマーゼ阻害剤及びその使用方法
IL160010A0 (en) *	2001-07-23	2004-06-20	Univ Ramot	Methods and compositions for treating fungal infections
MXPA04010555A (es) *	2002-04-25	2005-02-17	Pharmacia Corp	Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa.
WO2003105860A1 (fr) *	2002-06-14	2003-12-24	Novo Nordisk A/S	Utilisation pharmaceutique d'acides boroniques et de leurs esters
US20040147561A1 (en) *	2002-12-27	2004-07-29	Wenge Zhong	Pyrid-2-one derivatives and methods of use
WO2006050236A2 (fr) *	2004-11-01	2006-05-11	Nuada, Llc	Composes et methodes d'utilisation de ceux-ci
JP2008519853A (ja) *	2004-11-12	2008-06-12	トラスティーズオブタフツカレッジ	リパーゼ阻害物質
US7589239B2 (en) *	2005-09-02	2009-09-15	Auspex Pharmaceuticals	Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders

2008
- 2008-06-06 EP EP12178747.7A patent/EP2529793B1/fr not_active Not-in-force
- 2008-06-06 EP EP08828361A patent/EP2155705A4/fr not_active Withdrawn
- 2008-06-06 WO PCT/US2008/066028 patent/WO2009029317A2/fr not_active Ceased
- 2008-06-06 US US12/597,825 patent/US8653258B2/en active Active

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2063870A (en) *	1979-07-05	1981-06-10	Bellon Labor Sa Roger	1-aryl-4-arylsulphonyl-1h-pyrazolol-3 compounds and processes for their preparation
US5308860A (en) *	1993-01-15	1994-05-03	Rohm And Haas Company	Cyanosulfonylethyltriazoles
WO1999010321A2 (fr) *	1997-08-29	1999-03-04	The Johns Hopkins University	Composes antimicrobiens
US20040180829A1 (en) *	2000-05-10	2004-09-16	Bassler Bonnie L.	Compounds and methods for regulating bacterial growth and pathogenesis
WO2002047681A1 (fr) *	2000-12-14	2002-06-20	Unisearch Limited	Regulation de la virulence de bacteries
WO2003018029A1 (fr) *	2001-08-24	2003-03-06	Quorex Pharmaceuticals, Inc.	Agents antibacteriens bases sur une liaison toxoanion
WO2003077844A2 (fr) *	2002-03-13	2003-09-25	Takara Bio, Inc.	Effet d'un traitement au 4,5-dihydroxy- 2-cyclopentene-1-one (dhcp) sur l'expression genique et la densite bacterienne (quorum sensing)
WO2004004712A1 (fr) *	2002-07-09	2004-01-15	Fasgen, Llc	Methodes de traitement d'infections microbiennes chez les humains et les animaux
WO2005005598A2 (fr) *	2003-04-11	2005-01-20	New York University	Prevention et traitement des infections provoquees par b.anthracis : b.anthracis mutante ne possedant pas l'activite luxs, et inhibition par des furanones de la croissance et du 'quorum sensing'' par le biais de ai-2, et production de toxines
WO2005021559A2 (fr) *	2003-09-02	2005-03-10	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Oxazaborolidines constituant des effecteurs bacteriens
WO2005100384A2 (fr) *	2004-04-12	2005-10-27	The Trustees Of Princeton University	Composes ai-2 et analogues bases sur la structure lsrb de salmonella typhimurium

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
BARNIKOW, GUENTER ET AL: "Synthesis of CH-acidic thionocarboxylic acid esters", ZEITSCHRIFT FUER CHEMIE ( 1968 ), 8(9), 335 CODEN: ZECEAL; ISSN: 0044-2402, 1969 *
BRITSUN V N ET AL: "Cycloacylation of Phenylsulfonyl-N-R-thioacetamides by Compounds Containing an Activated Multiple Bond", CHEMISTRY OF HETEROCYCLIC COMPOUNDS, KLUWER ACADEMIC PUBLISHERS-CONSULTANTS BUREAU, NE, vol. 41, no. 11, 1 November 2005 (2005-11-01), pages 1437 - 1438, XP019276255, ISSN: 1573-8353 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1969, BARNIKOW, GUENTER ET AL: "Synthesis of CH-acidic thionocarboxylic acid esters", XP002683472, retrieved from STN Database accession no. 1969:11077 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1971, HUPPATZ, J. L.: "Convenient synthesis of ethyl sulfonylacetates", XP002683470, retrieved from STN Database accession no. 1971:87535 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1992, ZHOU, WEIQING ET AL: "Chemoselective oxidation of organic sulfides to sulfones with sodium perborate", XP002683473, retrieved from STN Database accession no. 1992:591428 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2001, ZAKRZEWSKI, ANDRZEJ ET AL: "Investigations of fungicidal properties of substituted phenylsulphonylacetic acid esters and amides", XP002683468, retrieved from STN Database accession no. 2001:824035 *
HUPPATZ, J. L.: "Convenient synthesis of ethyl sulfonylacetates", AUSTRALIAN JOURNAL OF CHEMISTRY ( 1971 ), 24(3), 653-5 CODEN: AJCHAS; ISSN: 0004-9425, 1971, XP002683471 *
LEE JIN YOUNG ET AL: "Radical alkylation of bis(silyloxy)enamine derivatives of organic nitro compounds.", ANGEWANDTE CHEMIE (INTERNATIONAL ED. IN ENGLISH) 18 SEP 2006 LNKD- PUBMED:16906611, vol. 45, no. 37, 18 September 2006 (2006-09-18), pages 6182 - 6186, XP002683469, ISSN: 1433-7851 *
LI MINYONG ET AL: "Structure-based discovery and experimental verification of novel Al-2 quorum sensing inhibitors against Vibrio harveyi", CHEMMEDCHEM, vol. 3, no. 8, August 2008 (2008-08-01), pages 1242 - 1249, XP002683475, ISSN: 1860-7179 *
PERSSON TOBIAS ET AL: "Rational design and synthesis of new quorum-sensing inhibitors derived from acylated homoserine lactones and natural products from garlic.", ORGANIC & BIOMOLECULAR CHEMISTRY 21 JAN 2005 LNKD- PUBMED:15632967, vol. 3, no. 2, 21 January 2005 (2005-01-21), pages 253 - 262, XP002683474, ISSN: 1477-0520 *
ZAKRZEWSKI, ANDRZEJ ET AL: "Investigations of fungicidal properties of substituted phenylsulphonylacetic acid esters and amides", PESTYCYDY (WARSAW) ( 2001 ), (1-2), 21-28 CODEN: PSTYDL; ISSN: 0208-8703, 2001 *
ZHONG ET AL: "Design and synthesis of quinolin-2(1H)-one derivatives as potent CDK5 inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 17, no. 19, 6 August 2007 (2007-08-06), pages 5384 - 5389, XP022249722, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2007.07.045 *
ZHOU, WEIQING ET AL: "Chemoselective oxidation of organic sulfides to sulfones with sodium perborate", WUJI HUAXUE XUEBAO ( 1992 ), 8(1), 88-90 CODEN: WHUXEO; ISSN: 1001-4861, 1992 *

Also Published As

Publication number	Publication date
WO2009029317A3 (fr)	2009-08-20
EP2155705A2 (fr)	2010-02-24
EP2155705A4 (fr)	2012-02-15
WO2009029317A2 (fr)	2009-03-05
EP2529793B1 (fr)	2016-08-10
EP2529793A2 (fr)	2012-12-05
US20100137249A1 (en)	2010-06-03
US8653258B2 (en)	2014-02-18

Publication	Publication Date	Title
EP2529793A3 (fr)	2013-03-20	Compositions pour la régulation ou la modulation de la détection de quorum dans des bactéries, procédés d'utilisation de ces composés et méthodes permettant de réguler ou moduler la détection de quorum dans des bactéries
WO2008011453A3 (fr)	2009-04-16	HÉTÉROCYCLES AROMATIQUES D'AZOLE SUBSTITUÉS, UTILISÉS EN TANT QU'INHIBITEURS DE LLβ-HSD-1
WO2008153793A3 (fr)	2009-03-19	Modulateurs de sécrétase gamma
WO2007133683A3 (fr)	2008-11-27	Compositions formulées anti-tiques et anti-insectes
WO2008116129A3 (fr)	2009-02-12	Analogues d'imidazolopyrimidine et leur utilisation comme inhibiteurs de pi3 kinase et de mtor
WO2008079460A3 (fr)	2008-10-16	Inhibiteurs de kinase pour la prévention ou le traitement d'une infection pathogène et procédé d'utilisation de ceux-ci
WO2008070016A3 (fr)	2008-09-12	Inhibiteurs de l'activité akt
WO2008073933A3 (fr)	2008-11-06	Composés 4-phényle-6-(2,2,2-trifluoro-1-phényléthoxy) à base de pyrimidine et procédés concernant leur utilisation
WO2010123919A3 (fr)	2011-03-03	Inhibiteurs pipéridiniques de la janus kinase 3
WO2009114810A3 (fr)	2009-12-23	Utilisation d'ellagitannines comme inhibiteurs de la détection du quorum bactérien
NZ594341A (en)	2012-10-26	Combinations of tralopyril and zinc chloride
GEP20125511B (en)	2012-05-10	Mapk/erk kinase inhibitors
CY1108794T1 (el)	2014-04-09	Σπειροκυκλικα παραγωγα κυκλοεξανιου
WO2008016662A3 (fr)	2008-03-13	Biocide pour liquides de stimulation et de traitement des puits
WO2011038318A3 (fr)	2011-09-22	Compositions comprenant du dibromomalonamide et leur utilisation comme biocides
MA32776B1 (fr)	2011-11-01	Inhibiteurs de l'akt et de la p70 s6 kinase
WO2009141541A3 (fr)	2010-04-29	Utilisation d' inhibiteurs de kif13a et d ' ap-1 pour inhiber la melanogenese
MX2012003739A (es)	2012-07-25	Composicones de dibromomalonamida y su uso como biocidas.
WO2009040952A1 (fr)	2009-04-02	Médicament renfermant un dérivé de benzophénone ou son sel
WO2009094560A3 (fr)	2010-01-14	Thiénopyranones en tant qu'inhibiteurs de kinase
FR2929509B1 (fr)	2011-01-21	L'utilisation de glycosides d'alkyle ou de melanges de glycosides d'alkyle en tant qu'agents destines a inhiber la croissance microbienne, et compositions contenant lesdits glycosides d'alkyle.
WO2009023664A3 (fr)	2009-07-23	Sulfonamides à substitution azépine et diazépine utilisés pour inhiber la 11-bêta-hydroxystéroïde déshydrogénase de type-1
MX2012003738A (es)	2012-04-30	Composiciones de dibromomalonamida y su uso como biocidas.
WO2008153792A3 (fr)	2009-05-07	Modulateurs de sécrétase gamma
MX345326B (es)	2017-01-25	Composiciones de dibromomalonamida y su uso como biocidas.

Legal Events

Date	Code	Title	Description
2012-12-04	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2012-12-05	AC	Divisional application: reference to earlier application	Ref document number: 2155705 Country of ref document: EP Kind code of ref document: P
2012-12-05	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2013-01-16	RIN1	Information on inventor provided before grant (corrected)	Inventor name: CHENG, YUNFEG Inventor name: WANG, BINGHE Inventor name: PENG, HANJING Inventor name: LU, CHUNG-DAR Inventor name: WAMG, JUNFENG Inventor name: LI, MINYONG Inventor name: NI, NANTIN Inventor name: ZHENG, SHILONG Inventor name: CHOU, HAN-TING
2013-02-15	PUAL	Search report despatched	Free format text: ORIGINAL CODE: 0009013
2013-02-20	RIN1	Information on inventor provided before grant (corrected)	Inventor name: LI, MINYONG Inventor name: NI, NANTIN Inventor name: WAMG, JUNFENG Inventor name: PENG, HANJING Inventor name: ZHENG, SHILONG Inventor name: CHENG, YUNFEG Inventor name: CHOU, HAN-TING Inventor name: LU, CHUNG-DAR Inventor name: WANG, BINGHE
2013-03-20	AK	Designated contracting states	Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2013-03-20	RIC1	Information provided on ipc code assigned before grant	Ipc: C07F 5/02 20060101ALI20130211BHEP Ipc: A61P 31/04 20060101AFI20130211BHEP Ipc: C07D 279/20 20060101ALI20130211BHEP Ipc: A61K 31/69 20060101ALI20130211BHEP Ipc: C07C 317/44 20060101ALI20130211BHEP Ipc: C07D 333/34 20060101ALI20130211BHEP Ipc: C07C 39/10 20060101ALI20130211BHEP Ipc: C07F 5/00 20060101ALI20130211BHEP
2013-10-30	17P	Request for examination filed	Effective date: 20130920
2013-10-30	RBV	Designated contracting states (corrected)	Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2014-05-21	17Q	First examination report despatched	Effective date: 20140416
2015-12-21	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2016-01-20	INTG	Intention to grant announced	Effective date: 20151222
2016-03-09	RIN1	Information on inventor provided before grant (corrected)	Inventor name: WANG, JUNFENG Inventor name: ZHENG, SHILONG Inventor name: WANG, BINGHE Inventor name: CHENG, YUNFEG Inventor name: PENG, HANJING Inventor name: LI, MINYONG Inventor name: LU, CHUNG-DAR Inventor name: NI, NANTING Inventor name: CHOU, HAN-TING
2016-03-30	RIN1	Information on inventor provided before grant (corrected)	Inventor name: PENG, HANJING Inventor name: LU, CHUNG-DAR Inventor name: WANG, JUNFENG Inventor name: ZHENG, SHILONG Inventor name: NI, NANTING Inventor name: LI, MINYONG Inventor name: CHENG, YUNFENG Inventor name: WANG, BINGHE Inventor name: CHOU, HAN-TING
2016-05-03	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2016-07-08	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2016-08-10	AC	Divisional application: reference to earlier application	Ref document number: 2155705 Country of ref document: EP Kind code of ref document: P
2016-08-10	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2016-08-10	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2016-08-15	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 818443 Country of ref document: AT Kind code of ref document: T Effective date: 20160815
2016-09-07	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2016-09-29	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602008045656 Country of ref document: DE
2016-12-12	REG	Reference to a national code	Ref country code: LT Ref legal event code: MG4D
2016-12-14	REG	Reference to a national code	Ref country code: NL Ref legal event code: MP Effective date: 20160810
2017-01-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MK05 Ref document number: 818443 Country of ref document: AT Kind code of ref document: T Effective date: 20160810
2017-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161210 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161110
2017-02-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161111 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161212 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810
2017-04-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810
2017-05-11	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602008045656 Country of ref document: DE
2017-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161110
2017-06-16	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2017-06-16	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2017-06-27	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10
2017-07-19	26N	No opposition filed	Effective date: 20170511
2017-08-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810
2018-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810
2018-01-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2018-03-21	REG	Reference to a national code	Ref country code: IE Ref legal event code: MM4A
2018-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170630 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170606 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170606 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170630
2018-06-26	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11
2018-08-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20180626 Year of fee payment: 11
2018-09-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170606
2018-10-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20180627 Year of fee payment: 11 Ref country code: GB Payment date: 20180627 Year of fee payment: 11
2019-06-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20080606
2019-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160810
2020-01-01	REG	Reference to a national code	Ref country code: DE Ref legal event code: R119 Ref document number: 602008045656 Country of ref document: DE
2020-02-26	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20190606
2020-03-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160810
2020-05-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200101 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190606
2020-06-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190630